EVH
Evolent Health Inc
4.10$
+7.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.4% | -1.4% | -6.4% | +1.1% | +1.7% | +4.3% | -7.2% | -0.3% | -22.6% | -1.1% | +5.0% | |
| – | +7.0% | -2.1% | -22.2% | +4.4% | +11.6% | +19.9% | -22.8% | +1.4% | -11.2% | -0.9% | +21.6% | |
| – | +4.5% | -14.4% | -38.7% | -4.6% | +7.9% | +136.6% | -38.8% | -22.7% | +30.2% | +9.3% | -30.3% | |
| – | +4.5% | -14.4% | -38.7% | -4.6% | +7.9% | +136.6% | -38.8% | -22.7% | +30.2% | +9.3% | -30.3% | |
| – | +13.3% | -4.3% | -12.6% | +9.1% | +1.7% | +3.8% | -16.7% | +7.8% | -16.3% | -2.9% | +43.0% | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -4.7% | +1.1% | +3.1% | +2.8% | +0.3% | – | – | |
| – | -0.1% | 0.0% | 0.0% | +1.9% | 0.0% | +0.0% | +0.0% | -5.4% | -35.4% | 0.0% | +0.0% | |
| – | -3.3% | -2.7% | -2.7% | -2.0% | -2.4% | -1.8% | -2.5% | +17.1% | -23.3% | -2.6% | -2.7% | |
| – | +2.5% | -1.0% | -10.9% | +2.9% | +5.5% | +11.3% | -8.9% | +2.9% | -7.9% | -0.1% | +7.2% | |
| – | +9.6% | -2.3% | -26.7% | +8.3% | +36.6% | +3.3% | -24.6% | -22.9% | -10.4% | -1.0% | +29.3% | |
| – | -30.2% | +30.4% | -51.7% | +1.4% | +3,086.2% | +4.4% | -5.1% | -88.3% | -33.5% | -42.8% | -82.4% | |
| – | -6.8% | +60.3% | -49.5% | +28.3% | +91.7% | -39.8% | +20.1% | +3.9% | -17.2% | +5.4% | -38.4% | |
| – | -0.5% | +0.1% | +0.1% | +0.1% | -18.2% | +32.0% | +0.1% | +62.7% | -8.0% | +0.3% | -0.7% | |
| – | -2.6% | -1.9% | +0.6% | -1.4% | -3.6% | -6.6% | -4.2% | -6.0% | -50.7% | -4.5% | -3.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.2% | +0.5% | +0.5% | +0.2% | +0.1% | +0.2% | +0.5% | -1.6% | +0.1% | -2.0% | +0.6% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.